Pregnancy may be one of the reasons why you are not getting your periods. But there are more causes of secondary amenorrhea.

Perhaps PD-1 inhibitors just aren’t for ovarian cancer after all. | Merck's and GSK's similar overall survival setbacks ...

Every woman has a one in 87 chance of getting ovarian cancer in her lifetime, and one in 130 will die from it. The symptoms ...

An MRI-based imaging technique developed at the University of Cambridge could be used to predict the response of ovarian ...

GSK said on Friday that adding its cancer drug Jemperli to both standard-of-care chemotherapy and Zejula as a maintenance ...

GSK's combined drugs Jemperli and Zejula met its primary goal of progression-free survival in patients with first line advanced ovarian cancer in a late-stage trial ... without cancer drug Bevacizumab ...

But new blood tests are emerging that use the power of artificial intelligence (AI) to spot signs of the cancer in its very ...

From reprogrammed stem cells to next-generation gene editing, 2024 has seen some incredible developments with the potential to become new treatments.

Company aligned with FDA on CMC strategy and requirements in preparation of Phase 3 pivotal trial of IMNN-001Vertical integration of major ...

For Alexis Warren, the journey with PCOS first began in her teens. She shares the lessons she's learned along the way.

WellTheory, a platform focused on reducing autoimmune disease symptoms, is launching a new women’s health program focused on ...

Physicians at the University of Oklahoma Health Sciences are leading a national clinical trial over an investigational device ...